Growth Strategy Applied: GSK Oral Care, Consumer Biz. Up In Q2

摘要

GlaxoSmithKline's oral-care business thrived in the second quarter of 2009, and CEO Andrew Witty makes it sound simple: "We've innovated our products and we advertise our products at the right level," he said during GSK's July 22 earnings call. U.S. sales for the UK company's oral-care segment -which includes five of the top 10 U.S. toothpaste stock-keeping units - shot up 10 percent to $116.9 million in the fiscal 2009 second quarter ended June 30.